Crazy timing, was just going over this with an LLM about the same time this got posted this morning. Do the providers explicitly call out traits like Height and IQ—or just disease risk? Also how does being from a population likely underrepresented in the data affect accuracy (for example I don’t see Central Asian in the Herasight drop down).
Herasight does height, IQ, and a few other non-disease triats like eye color and hair color. Stuff like facial appearance or athletic performance aren’t well enough understood yet for anyone to offer precitors. They’ll probably have personality predictors at some point in the next year or so, but that’s TBD.
Nucleus offers stuff like this too, but for reasons explained in the article, I would avoid using them for the time being.
Orchid and Genomic Prediction only offer screening for disease related things at the moment.
Central asians are probably somewhere between east asians, middle easterners, and Europeans genetically, so I’d guess you’d see a reduction of maybe 15-25% in the expected gain for them relative to Europeans.
Crazy timing, was just going over this with an LLM about the same time this got posted this morning. Do the providers explicitly call out traits like Height and IQ—or just disease risk? Also how does being from a population likely underrepresented in the data affect accuracy (for example I don’t see Central Asian in the Herasight drop down).
Herasight does height, IQ, and a few other non-disease triats like eye color and hair color. Stuff like facial appearance or athletic performance aren’t well enough understood yet for anyone to offer precitors. They’ll probably have personality predictors at some point in the next year or so, but that’s TBD.
Nucleus offers stuff like this too, but for reasons explained in the article, I would avoid using them for the time being.
Orchid and Genomic Prediction only offer screening for disease related things at the moment.
Central asians are probably somewhere between east asians, middle easterners, and Europeans genetically, so I’d guess you’d see a reduction of maybe 15-25% in the expected gain for them relative to Europeans.